Compass Pathways Plc (CMPS)
8.12
+0.14
(+1.75%)
USD |
NASDAQ |
Nov 18, 16:00
8.22
+0.10
(+1.23%)
After-Hours: 06:15
Compass Pathways Debt to Equity Ratio : 0.3829 for Sept. 30, 2026
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2026 | 0.3829 |
| June 30, 2026 | 0.6462 |
| March 31, 2026 | 0.1632 |
| December 31, 2025 | -0.6629 |
| September 30, 2025 | 0.936 |
| June 30, 2025 | 0.2171 |
| March 31, 2025 | 0.1639 |
| December 31, 2024 | 0.2081 |
| September 30, 2024 | 0.1686 |
| June 30, 2024 | 0.1442 |
| March 31, 2024 | 0.1266 |
| December 31, 2023 | 0.1464 |
| September 30, 2023 | 0.1285 |
| Date | Value |
|---|---|
| June 30, 2023 | 0.1974 |
| March 31, 2023 | 0.0094 |
| December 31, 2022 | 0.0106 |
| September 30, 2022 | 0.0116 |
| June 30, 2022 | 0.0133 |
| March 31, 2022 | 0.0115 |
| December 31, 2021 | 0.0127 |
| September 30, 2021 | 0.00 |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | 0.00 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Silence Therapeutics Plc | 0.0004 |
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | 0.034 |
| Mereo BioPharma Group Plc | 0.0243 |
| HemoGenyx Pharmaceuticals Plc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 519.10M |
| Total Liabilities (Quarterly) | 377.03M |
| Shareholders Equity (Quarterly) | 142.07M |
| Current Ratio | 1.496 |
| Net Debt Paydown Yield | -0.22% |